XML 85 R23.htm IDEA: XBRL DOCUMENT v3.25.1
EQUITY
12 Months Ended
Dec. 31, 2024
EQUITY  
EQUITY

18.EQUITY

18.1 SHARE CAPITAL

Authorized Share Capital

Unlimited number of common shares voting and participating, with no par value. All issued ordinary shares are fully paid.

    

December 31, 2024

    

December 31, 2023

Shares issued at the start of the period

 

60,903,898

 

55,873,898

Shares issued from offering

 

 

4,850,000

Shares issued - Lac Guéret Property acquisition (Note 19)

6,208,210

Shares issued from Private Placements (Note 16)

83,432,538

Options exercised (Note 18.2)

137,500

 

180,000

Settlement of interest on Convertible Notes (Note 15)

1,579,043

Shares issued at the end of period

 

152,261,189

60,903,898

On April 17, 2023, the Company concluded an underwritten public offering agreement for 4,850,000 common shares, at a price of US$4.55 per share for gross proceeds of $29.6M (US$22M). The offering was conducted on a bought deal basis and the Company incurred underwriter fees equal to 6% of the gross proceeds.

18.2 SHARE-BASED PAYMENTS

The Board of Directors determines the price per common share and the number of common shares which may be allocated to each director, officer, employee and consultant and all other terms and conditions of the option, subject to the rules of the TSX. The plan has a policy that caps the maximum of total options that can be granted to 10% of the total outstanding shares of the Company.

All share-based payments will be settled in equity. The Company has no legal or contractual obligation to repurchase or settle the options in cash.

The Company’s share options are as follows:

December 31, 2024

December 31, 2023

Weighted average

Weighted average

exercise price

exercise price

Number

$

Number

$

Opening balance

4,908,548

6.79

3,911,804

7.42

Granted

4,317,500

3.07

2,088,548

5.51

Exercised

(137,500)

 

2.35

 

(180,000)

 

3.20

Expired

(346,000)

 

6.64

 

(337,000)

 

6.52

Forfeited

(295,000)

 

3.51

 

(87,000)

 

5.39

Cancelled

(453,048)

 

8.20

 

(487,804)

 

8.20

Ending balance

7,994,500

 

4.90

 

4,908,548

 

6.79

Options that can be exercised

3,174,750

 

7.30

 

2,824,000

 

7.64

The weighted average share price at the time of exercise for 2024 was $2.35 ($4.52 in 2023).

The details of the share options granted by the Company are as follows for the years ended December 31, 2024 and 2023:

    

December 31, 2024

    

December 31, 2023

Directors

 

262,500

 

212,500

Officers

 

2,200,000

 

600,000

Employees

1,705,000

 

800,000

Consultants

 

150,000

476,048

Total granted share options

4,317,500

2,088,548

The vesting period for the options granted during the year ended December 31, 2024 occurs in two annual tranches, except for some options granted to key employees that vest upon FID, subject to certain conditions. Each option entitles the holder to subscribe to one common share of the Company, at an average price of $3.07 ($5.51 for 2023) per common share, for a period of 5 years (4.49 years in 2023). Total expenses arising from share-based transactions recognized during the year amount to $4,291 ($3,569 in 2023) out of which $361 ($508 in 2023) have been capitalized in property, plant and equipment.

The weighted average fair value of the share options granted were estimated using the Black-Scholes option pricing model based on the following average assumptions:

2024

    

2023

 

Share price at date of grant

$

3.07

$

5.51

Expected life

5 years

 

4.49 years

Risk-free interest rate

3.51

%

3.11

%

Expected volatility

80.79

%

74.03

%

Expected dividend

nil

 

nil

Fair value per option

$

2.04

$

3.22

The expected annualized volatility was based on historical data for the Company. The fair value of the share options is amortized over the vesting period, considering expected forfeitures. The strike price of share options issued are exercisable at the share’s closing price on the last trading day prior to the grant.

    

As at December 31, 2024

Weighted average

exercise price

Expiration date

Total number

Total exercisable

$

2025

737,500

737,500

3.21

2026

450,000

450,000

16.26

2027

 

1,219,000

1,219,000

 

8.07

2028

 

1,485,500

768,250

 

4.76

2029

 

4,102,500

 

3.07

Ending balance

 

7,994,500

3,174,750

 

4.90